Dynamics of Holter electrocardiogram monitoring in patients with chronic heart failure and atrial fibrillation on the background of cardiac contractility modulation
- Authors: Safiullina A.A.1, Uskach T.M.1,2, Sharapova Y.S.1, Kochetov A.G.3,4, Sapelnikov O.V.1, Tereshchenko S.N.1,2
-
Affiliations:
- National Medical Research Center of Cardiology
- Russian Medical Academy of Continuous Professional Education
- People’s Friendship University of Russia (RUDN University)
- Institute of Laboratory Medicine
- Issue: Vol 93, No 9 (2021)
- Pages: 1044-1051
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/82968
- DOI: https://doi.org/10.26442/00403660.2021.09.201034
- ID: 82968
Cite item
Full Text
Abstract
Aim. To evaluate the dynamics of cardiac arrhythmias on the background of cardiac contractility modulation (MCC) in patients with chronic heart failure (CHF) and various forms of atrial fibrillation (AF) on the basis of daily electrocardiogram (ECG) monitoring.
Materials and methods. In 100 patients with CHF and AF, the following studies were performed before implantation of the MCC device and after 12 months of follow-up: 12-channel ECG with an estimate of the width of the QRS complex, transthoracic echocardiography (EchoCG), and Holter ECG monitoring. All patients received long-term optimal drug therapy for CHF before surgery.
Results. The results obtained indicate that there is no effect of MCC on the development and progression of ventricular arrhythmias in patients with CHF and AF during the year of follow-up, both extrasystole and tachyarrhythmias, regardless of the etiology and LVEF (less than 35% or more than 35%), and a decrease in the frequency of AF paroxysms in patients with CHF during treatment. These results are due to the reverse remodeling of the LV myocardium under the influence of the MCC device.
Conclusion. The use of MСС in patients with CHF and AF is a safe method of therapy that does not induce cardiac arrhythmias, including ventricular extrasystole. Large-scale comparative studies are required to evaluate these results.
Full Text
##article.viewOnOriginalSite##About the authors
Alfiya A. Safiullina
National Medical Research Center of Cardiology
Author for correspondence.
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-3483-4698
канд. мед. наук, науч. сотр. отд. заболеваний миокарда и сердечной недостаточности Института клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии»
Russian Federation, MoscowTatiana M. Uskach
National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-4318-0315
д-р мед. наук, вед. науч. сотр. отд. заболеваний миокарда и сердечной недостаточности Института клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии», проф. каф. кардиологии ФГБУ ДПО РМАНПО
Russian Federation, Moscow; MoscowYulduz S. Sharapova
National Medical Research Center of Cardiology
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-4767-198X
врач-аспирант отд. заболеваний миокарда и сердечной недостаточности Института клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии»
Russian Federation, MoscowAnatolii G. Kochetov
People’s Friendship University of Russia (RUDN University); Institute of Laboratory Medicine
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-3632-291X
д-р мед. наук, проф. каф. госпитальной терапии с курсом клинической лабораторной диагностики ФГАОУ ВО РУДН, ректор АНО ДПО «Институт лабораторной медицины»
Russian Federation, Moscow; MoscowOleg V. Sapelnikov
National Medical Research Center of Cardiology
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-5186-2474
д-р мед. наук, рук. лаб. хирургических и рентгенохирургических методов лечения нарушений ритма сердца отд. сердечно-сосудистой хирургии ФГБУ «НМИЦ кардиологии»
Russian Federation, MoscowSergey N. Tereshchenko
National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education
Email: a_safiulina@mail.ru
ORCID iD: 0000-0001-9234-6129
д-р мед. наук, проф., рук. отд. заболеваний миокарда сердечной недостаточности Института клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии», зав. каф. кардиологии ФГБУ ДПО РМАНПО
Russian Federation, Moscow; MoscowReferences
- Klein L, Hsia H. Sudden cardiac death in heart failure. Cardiol Clin. 2014;32:135-44. doi: 10.1016/j.ccl.2013.09.008
- Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985;72:681-5. doi: 10.1161/01.cir.72.4.681
- Zipes DP. Epidemiology and mechanisms of sudden cardiac death. Can J Cardiol. 2005;21(Suppl. A):37A-40A
- Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120:2170-6. doi: 10.1161/CIRCULATIONAHA.109.853689
- Хроническая сердечная недостаточность. Клинические рекомендации 2020. Рос. кардиол. журн. 2020;25(11):4083 [Russian Society of Cardiology (RSC) 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083 (in Russian)]. doi: 10.15829/29/1560-4071-2020-4083
- Mando R, Goel A, Habash F, et al. Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hindawi Cardiovascular Therapeutics. 2019;10. doi: 10.1155/2019/9769724
- Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a predictor of mortality in chronic heart failure? Int J Cardiol. 1999;70:171-8. doi: 10.1016/s0167-5273(99)00077-7
- Iuliano S, Fisher SG, Karasik PE, et al. QRS duration and mortality in patients with congestive heart failure. Am Heart J. 2002;143(6):1085-91. doi: 10.1067/mhj.2002.122516
- Grigioni F, Carinci V, Boriani G, et al. Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant. 2002;21(8):899-902. doi: 10.1016/s1053-2498(02)00431-x
- Roger S, Michels J, Heggemann F, et al. Long term impact of cardiac contractility modulation on QRS duration. J Electrocardiol. 2014;47(6):936-40. doi: 10.1016/j.jelectrocard.2014.08.011
- Duncker D, Veltmann C. Device therapy in heart failure with reduced ejection fraction–cardiac resynchronization therapy and more. Herz. 2018;43(5):415-22. doi: 10.1007/s00059-018-4710-6
- Morita H, Suzuki G, Haddad W, et al. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail. 2003;9:69-75. doi: 10.1054/jcaf.2003.8
- Imai M, Rastogi S, Gupta RS, et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol. 2007;49:2120-8. doi: 10.1016/j.jacc.2006.10.082
- Sabbah HN, Haddad W, Mika Y, et al. Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure. Heart Fail Rev. 2001;6:45-53. doi: 10.1023/a:1009855208097
- Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008;51:1784-9. doi: 10.1016/j.jacc.2008.01.036
- Rastogi S, Mishra S, Zaca V, et al. Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure. Cardiology. 2008;110:230-7. doi: 10.1159/000112405
- Burkhoff D, Shemer I, Felzen B, et al. Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo. Heart Fail Rev. 2001;6(1):27-34. doi: 10.1023/a:1009851107189.
- Zhang F, Dang Y, Li Y, et al. Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure. Cell Physiol Biochem. 2016;39(1):294-302. doi: 10.1159/000445624
- Pappone C, Augello G, Rosanio S, et al. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol. 2004;15:418-27. doi: 10.1046/j.1540-8167.2004.03580.x
- Stix G, Borggrefe M, Wolpert C, et al. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J. 2004;25:650-5. doi: 10.1016/j.ehj.2004.02.027
- Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29:1019-28. doi: 10.1093/eurheartj/ehn020
- Wiegn P, Chan R, Jost C, et al. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study. Eur Heart J. 2008;29(8):1019-28. doi: 10.1161/CIRCHEARTFAILURE.119.006512
![](/img/style/loading.gif)